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Background: Mitogen-activated protein (MAP) kinase
is central to a signal transduction pathway that triggers
cell proliferation or differentiation. Activation of the
p42mapk isoform requires its phosphorylation at two
residues, Thr 183 and Tyr 185, and this phosphorylation
is catalysed by MAP kinase kinase (MAPKK). Relatively
little is known, however, about the enzymes that
dephosphorylate these residues, thereby inactivating the
pathway. Recently, the CL100 phosphatase has been
shown to inactivate p42mapk in vitro by dephosphorylat-
ing Thr 183 and Tyr 185 at similar rates. CL100, the
product of an immediate early gene, is synthesized
within one hour of stimulating cells with growth factors
or exposure to oxidative stress or heat shock. Incubation
of NIH 3T3 fibroblasts with cycloheximide prevents
both synthesis of CL100 and inactivation of p42mapk after
stimulation with serum.
Results: Depleting cells of CL100 and preventing its
induction using cycloheximide stopped the inactivation
of p42mapk in Swiss 3T3 fibroblasts following stimulation
with epidermal growth factor (EGF), but had no effect on
the rapid inactivation of p42mapk in response to EGF in
adipose (3T3-L1) or chromaffin (PC12) cells or in
response to platelet-derived growth factor (PDGF) in
endothelial (PAE) cells. Moreover, maximal induction of
CL100 mRNA and a CL100-like activity did not trigger
inactivation of p42mapk, which was sustained at a high
level after stimulation of PC12 cells with nerve growth
factor, PAE cells with serum, or Swiss 3T3 cells with
PDGF. Dephosphorylation of Tyr 185 but not Thr 183
of p42mapk was suppressed by vanadate in EGF-stimulated
PC12 cells; dephosphorylation of Thr 183, by contrast,
was elicited by a vanadate-insensitive activity. Protein
phosphatase-2A was the only vanadate-insensitive phos-
phatase acting on Thr 183 of p42mapk or on MAPKK
to be detected in PC12 cell extracts. Phosphorylation
of Thr 183 also inhibited the dephosphorylation of
Tyr 185 in vitro by the major vanadate-sensitive Tyr 185-
specific phosphatase, explaining why dephosphorylation
of Thr 183 is rate-limiting for p42mapk inactivation in
PC12 cells after stimulation with EGF.
Conclusions: The rapid inactivation of p42 maPk initiated
five minutes after stimulation of endothelial, adipose and
chromaffin cells with growth factor is not catalysed by
CL100, but rather by protein phosphatase 2A and by
a protein tyrosine phosphatase distinct from CL100. In-
duction of CL100 is not accompanied by the inactivation
of p42mapk in a number of situations.
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Background
The activation of mitogen-activated protein (MAP)
kinase is a key event in signalling by growth factors [1]
and the prolonged activation of this enzyme above a crit-
ical threshold is required to trigger mitogenesis in fibrob-
lasts [2,3] or the differentiation of phaeochromocytoma
(PC12) cells [3,4]. The sustained activation of MAP
kinase seems to be required for its translocation from the
cytosol to the nucleus [5,6], where it is thought to regu-
late proteins that control the transcription of genes
important for proliferation and/or differentiation.
The activation of MAP kinase involves phosphorylation
of a threonine and a tyrosine residue [7] and is catalysed
by MAP kinase kinase (MAPKK). These residues are
located in a Thr-Glu-Tyr sequence (residues 183-185
of the p42mapk isoform [8]), and the recently deduced
atomic structure of inactive p42mapk has provided insight
as to why both residues are required for activation.
Phosphorylation of Thr 183 probably permits the correct
alignment of catalytic residues, while the phosphorylation
of Tyr 185 may facilitate the recognition and binding of
protein substrates [9].
The activation of MAPKK by growth factors involves the
phosphorylation of two serines (Ser 217 and Ser 221 in
the MAPKK1 isoform) and is catalysed by several protein
kinases including a Ras-regulated enzyme called c-Raf
(or p74raf- 1) [10,11]. Ser217 and Ser221 lie between
subdomains VII and VIII of the MAPKK catalytic
domain, in an equivalent location to that of Thr 183 and
Tyr 185 of p42mapk. However, in contrast to p42mapk,
phosphorylation of either Ser 217 or Ser 221 of MAPKK
is sufficient for maximal activation, and dephosphoryla-
tion of both residues is required for inactivation [10].
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The protein phosphatases that inactivate MAP kinase
and MAPKK must play critical roles in determining the
levels of activation of these enzymes in vivo, but their
identities are unclear. The catalytic subunits of protein
phosphatase-1 (PP1) and protein phosphatase-2A
(PP2A) inactivate MAPKK in vitro, PP2A being much
more effective [12,13]; Thr 183 of p42mapk is also
dephosphorylated by PP2A [7] and Tyr 185 by a variety
of protein tyrosine phosphatases [7,12,14]. Recently, a
'dual specificity' protein phosphatase has been identified,
which dephosphorylates Thr 183 and Tyr 185 of
p42mapk at similar rates in vitro [15-17]. This phos-
phatase, named CL100 [18] or MAP kinase phosphatase-
1 [16], is structurally related to the family of protein
tyrosine phosphatases and is highly specific for MAP
kinase in vitro.
CL100 is the product of an immediate early gene and is
synthesized rapidly in response to various extracellular
stimuli. It has a half-life of 40-60 minutes and therefore
disappears from cells that are incubated for several hours
with the protein synthesis inhibitor, cycloheximide.
CL100 mRNA and protein are barely detectable in qui-
escent cells, but both increase 20-fold or more within
60 minutes of cells being stimulated with growth factors
of exposed to chemical or oxidative stress [18,19]. In
NIH 3T3 fibroblasts, the inactivation of p42mapk is initi-
ated 60 minutes after stimulation with serum, the time at
which the CL100 protein first appears - but cyclohex-
imide is able to block the appearance of CL100, result-
ing in the persistent activation of p42mapk. Furthermore,
the overexpression of CL100 in COS cells, triggered by
serum or oncogenic forms of Ras or Raf, leads to the
dephosphorylation of p42mapk [16]. These experiments
suggested that CL100 might be the enzyme that inacti-
vates p42maPk in fibroblasts, although the possibility that
cycloheximide blocks the synthesis of another protein
that is essential for the inactivation of p42mapk was not
excluded by these experiments.
In many cells the activation of MAP kinase and MAPKK
by some extracellular agonists is transient, peaking after
a few minutes and returning to basal levels after
15-60 minutes. This is seen, for example, after stimula-
tion of Chinese hamster lung CCL39 fibroblasts with
phorbol esters or carbachol [20], or stimulation of rat
PC12 cells with epidermal growth factor (EGF) [6]. In
these situations the inactivation of MAP kinase is initi-
ated after 5 minutes, which may be too rapid to be
explained by de novo synthesis of CL100. Here, we
demonstrate that maximal induction of CL100 is not
accompanied by the inactivation of p42maPk in several
cell types. Moreover, the rapid inactivation of p42mapk,
occurring within minutes after stimulation by some
growth factors is not mediated by CL100 in chromaffin,
endothelial and adipocyte cell lines. Instead, we present
evidence that the inactivation of p42mapk is likely to
be catalysed by PP2A in conjunction with an, as yet
unidentified, protein tyrosine phosphatase(s).
Results
Effect of cycloheximide on the activation and inactivation of
p42mapk and MAPKK by growth factors in Swiss 3T3 cells
Sun et al. [16] have shown that in serum-stimulated NIH
3T3 fibroblasts, p42mapk is activated maximally after
5 minutes and activity is sustained for at least 1 hour
before declining to near basal levels after 4 hours. The
inactivation is prevented by incubating the cells with
cycloheximide. Somewhat similar observations were
made in the present work, after EGF stimulation of Swiss
3T3 fibroblasts: cycloheximide stopped the decline in
p42 mapk activity after 30 minutes, but not the decline
before 30 minutes (Fig. la). The effect of cycloheximide
could be explained by the failure to synthesize a protein
essential for the inactivation of p42mapk or a protein
required to switch off MAPKK activity. However, cyclo-
heximide had no effect on the activation or inactivation
of MAPKK in EGF-stimulated Swiss 3T3 fibroblasts
(Fig. b). Activation of MAPKK, in this case, was
extremely transient, peaking after 5 minutes and return-
ing to near basal levels after 15 to 30 minutes (Fig. lb).
Thus, cycloheximide must exert its effect by preventing
Fig. 1. Effect of cycloheximide on the
activation and inactivation of p42mapk
and MAPKK in response to EGF in Swiss
3T3 fibroblasts. Cells were incubated for
3 h in the absence (open circles) or
presence (closed circles) of 40 pg ml- l
cycloheximide, then stimulated with
EGF (in the continued absence or pres-
ence of cycloheximide). The cells were
lysed and assayed for (a) p42mapk and(b) MAPKK. Similar results were
obtained in three different experiments.
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Fig. 2. Effect of cycloheximide on the
activation and-- inactivation of MAP
kinase in endothelial (PAE), adipose
(3T3-L1) and chromaffin (PC12) cell
lines. Cells were incubated for 3 h in
the absence (open circles) or presence
(closed circles) of 40 p±g ml-1 cyclohex-
imide and then stimulated with the
growth factors shown for the times indi-
cated (in the continued absence or pres-
ence of cycloheximide). Cells were then
lysed and assayed for (a,b) p42mapk after
immunoprecipitation or (c,d) for total
MAP kinase activity (p42mapk plus
p44mapk). Similar results were obtained
in three different experiments.
the synthesis of a protein required for p4 2mapk inactiva-
tion, and not of a protein required to inactivate MAPKK.
Effect of cycloheximide on the activation and inactivation
of p4 2maPk and MAPKK in response to growth factors in
non-fibroblast cells
In order to examine whether the effect of cycloheximide
on p42mapk activation was common to all mammalian
cells, we repeated the experiments described above using
atrial endothelial (PAE) cells stably transfected with the
gene encoding the receptor for platelet-derived growth
factor (PDGF), 3T3-L1 adipocytes, and chromaffin
(PC12) cells. Stimulation of PAE cells with PDGF
(Fig. 2a) and 3T3-L1 or PC12 cells with EGF (Figs 2b
and 2c) induced a transient activation of p42mapk, peak-
ing after 5 minutes and returning to near basal levels after
15-60 minutes. In contrast to the situation in fibroblasts,
cycloheximide had no effect on the rapid inactivation of
p42mapk in these cells.
Nerve growth factor (NGF) triggers the activation of
MAPKK [6] and MAP kinase in PC12 cells. The activa-
tion of MAP kinase is largely sustained for 2 hours in the
presence or absence of cycloheximide (Fig. 2d), and even
for up to 6 hours (data not shown). We also found that
the removal of NGF from the cell medium was without
effect on the inactivation of MAP kinase, which occurred
when NGF was withdrawn after either 10 minutes or after
1 hour. At both time points, MAP kinase activity declined
by about 50% after 30 minutes (data not shown).
Stimulation of PAE cells with serum, or Swiss 3T3 cells
with PDGF, induced an activation of p42mapk that was
sustained for at least 2 hours (Figs 3a and 3c), although in
contrast to NGF-stimulated PC12 cells, the activation of
MAPKK was extremely transient (Figs 3b and 3d).
Neither the activation of p42mapk, nor the activation of
MAPKK, was sensitive to cycloheximide.
Induction of CL100 mRNA and its MAP kinase
phosphatase activity
In order to investigate further the potential role of
CL100 in regulating MAP kinase inactivation, we mea-
sured the level of CL100 mRNA after stimulation of cells
with growth factors. In quiescent Swiss 3T3 cells, CL100
mRNA was low, but increased five-fold after stimulation
for 30 minutes with EGF or for 60 minutes with PDGF
(Fig. 4a). In quiescent PAE cells (Fig. 4b), the level of
CL100 mRNA was equally low, but it increased three-
fold after stimulation for 30 minutes with PDGF and
eight-fold after stimulation for 1 hour with serum. In
PC12 cells, the level of CL100 mRNA increased 8-fold
and 25-fold after stimulation for 2 hours with EGF and
NGF, respectively (Figs 5a and 5b). Thus, CL100 mRNA
levels were highest under conditions in which MAP
kinase activation was sustained - in NGF-stimulated
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Fig. 3. Effect of cycloheximide on
p42mapk and MAP kinase kinase activa-
tion in endothelial (PAE) and fibroblast
(Swiss 3T3) cell lines. Cells were in-
cubated for 3 h in the absence (open
circles) or presence (closed circles) of
40 tg ml- 1 cycloheximide and then
stimulated with serum or PDGF for the
times indicated (in the continued
absence or presence of cycloheximide).
The cells were lysed and assayed for
p42mapk after immunoprecipitation (a,c)
or for MAPKK activity (b,d). Similar
results were obtained in three different
experiments.
PC12 cells (Fig. 2d), serum-stimulated PAE cells (Fig. 3a) and PC12 cells [21], but the enzymatic activity of CL100
and PDGF-stimulated Swiss 3T3 cells (Fig. 3c) - and in cell extracts has not been measured previously. In order
low under conditions in which MAPKK and p42mapk are to explore the feasibility of measuring CL100 activity
inactivated rapidly - in EGF-stimulated PC12 cells directly from cell lysates, we initially examined the
(Fig. 2c) and in PDGF-stimulated PAE cells (Fig. 2a). dephosphorylation, in PC12 cell extracts, of p42mapk at
Thr 183 and Tyr 185. Lysates from unstimulated cells or
The level of CL100 mRNA has been shown to correlate cells stimulated for 15 minutes with NGF were capable
closely with the level of CL100 protein in fibroblasts [16] of completely dephosphorylating Thr 183 and Tyr 185
Fig. 4. Accumulation of the CL100
mRNA in response to growth factor in
Swiss 3T3 and PAE cells. The induction
of CL100 mRNA was measured in (a)
Swiss 3T3 cells after stimulation with
EGF (black squares) or PDGF (grey cir-
cles); and in (b) PAE cells stimulated
with PDGF (grey circles) or serum (open
circles). The levels of CL100 mRNA are
presented relative to those of glycer-
aldehyde-3-phosphate dehydrogenase
mRNA. Similar results were obtained
with two separate northern blots.
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(Fig. 6a, lanes 7 and 8). The dephosphorylation of
Tyr 185 was inhibited specifically by sodium orthovana-
date (hereafter referred to as vanadate), an inhibitor of
protein tyrosine phosphatases (Fig. 6a, lanes 3 and 4),
whereas the dephosphorylation of Thr 183 was inhibited
specifically by microcystin-LR, an inhibitor of the pro-
tein serine/threonine phosphatase family that includes
PP1 and PP2A (Fig. 6a, lanes 5 and 6) [22]. In the pres-
ence of both vanadate and microcystin, dephosphoryla-
tion of both Thr 183 and Tyr 185 was abolished (Fig. 6a,
lanes 1 and 2). The absence of vanadate-sensitive Thr 183
phosphatase activity - the hallmark of CL100 activity -
indicated that CL100 was not a significant Thr 183 phos-
phatase under these conditions. But after prolonged (1-4
h) stimulation of PC12 cells with NGF, a vanadate-sensi-
tive (microcystin-insensitive) Thr 183 phosphatase activ-
ity could be detected in the lysates (Fig. 6b, lanes 1 and
2), and the appearance of this activity was blocked by
cycloheximide (Fig. 6b, lanes 3 and 4).
In Figure 7, we quantify the induction of CL100-like
activity following growth factor stimulation of PC12
and PAE cells. The vanadate-sensitive p42mapk phos-
phatase activity in PC12 cell lysates increased three-fold
after stimulation with NGF for 1 hour and five-fold
after 6 hours, and by 50 % after a 1 hour stimulation
with EGF (Fig. 7a). However, as the vanadate-sensitive
p42mapk phosphatase activity in unstimulated cells is due
to a distinct Tyr 185 specific phosphatase (Fig. 6a),
induction of the CL100-like activity by NGF and EGF
is least 30-50-fold higher and therefore parallels, tem-
porally and quantitatively, the increase in CL100
mRNA (Fig. 5).
We also compared the induction of a CL100-like activity
in wild-type PC12 cells with that in PC12 cells over-
expressing HER(A1039-1053), a mutant human EGF
receptor which lacks residues 1039-1053 and is unable to
'down-regulate' its signalling activity [4]. Treatment of
wild-type PC12 cells with EGF resulted in the transient
activation of p42mapk (Fig. 2c), inducing CL100-like
activity less than did treatment with NGF (Fig. 7a),
and did not induce differentiation. In contrast, stimu-
lation with EGF of PC12 cells expressing the
HER(A1039-1053) triggered a sustained activation of
MAP kinase [4], a robust and sustained induction of
CL100-like phosphatase activity (Fig. 7a), and promoted
differentiation of the cells to a sympathetic neuron-like
phenotype, similar to that triggered by NGF [4]. These
results suggest that rapid desensitization of the EGF
receptor may account for the smaller and more transient
induction of CL100-like activity by EGF in untransfected
wild-type PC12 cells.
Similar observations were made in PAE cells. Stimulation
with serum caused a sustained activation of p42mapk (Fig.
2a), and induced a three-fold increase in a vanadate-sen-
sitive p42maPk phosphatase activity after 1 hour (Fig. 7b),
the appearance of which was blocked by cycloheximide.
Stimulation with PDGF caused a transient activation of
Fig. 5. NGF and EGF increase the levels of CL100 mRNA in
PC12 cells. (a) The induction of CL100 mRNA was examined by
northern blotting in EGF- and NGF-stimulated rat (r) PC12 cells.
Both blots were re-probed with a fragment of the rat glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) cDNA as a loading
control. (b) The hybridization signals were quantitated relative to
GAPDH mRNA; EGF (black squares), NGF (open squares).
Similar results were obtained in two separate experiments.
p42mapk (Fig. 2a) and a smaller increase in the vanadate-
sensitive p42mapk phosphatase (Fig. 7b).
Taken together, the experiments described above esta-
blish that the induction of a CL100-like activity parallels
the rise in CL100 mRNA, and demonstrate that maxi-
mal induction of CL100-like activity is not accompanied
by the inactivation of MAP kinase following stimulation
of PC12 cells with NGF, or PAE cells with serum.
Identification of PP2A as the major phosphatase acting on
p42maPk and MAPKK in extracts from unstimulated
PC12 cells
The results presented above prompted us to identify the
microcystin-sensitive and vanadate-sensitive protein phos-
phatases which inactivated p42mapk and MAPKK. Four
major types of protein serine/threonine phosphatase cata-
lytic subunit have been identified in mammalian tissues:
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Fig. 6. Dephosphorylation of Thr 183 and Tyr 185 of p42mapk by PC12 cell extracts. (a) PC12 cells were incubated for 15 min in the
absence (-) or presence (+) of NGF and in the absence of cycloheximide (CHX). The cells were then lysed in the presence of 2 I.M
microcystin (MC) and 1 mM sodium orthovanadate (V) (lanes 1 and 2), with 1 mM vanadate alone (lanes 3 and 4), with 2 F.M micro-
cystin alone (lanes 5 and 6) or in the absence of either phosphatase inhibitor (lanes 7 and 8). Extract (0.01 ml; 20 IPg protein) was incu-
bated for 60 min at 30 C with 0.01 ml [32P]-labelled p42maPk. Trichloroacetic acid (0.2 ml; 20 % (w/v)) was then added and the
suspension centrifuged for 5 min at 14 000 x g. The supernatant was discarded, the pellet washed three times with-diethyl ether and
dried. Samples were then incubated for 90 min at 110 C in 6 M HCI, electrophoresed on thin layer cellulose at pH 3.5 to resolve
phosphoserine (pS), phosphothreonine (pT), phosphotyrosihe (pY)'and orthophosphate (Pi) [13], and autoradiographed. (b) PCI2 cells
were stimulated for 4 h with NGF in the absence (lanes 1 and 2) or presence (lanes 3 and 4) of 40 p.g ml-1 CHX, lysed in the presence
of 2 ,aM MC, and 0.01 ml extract was incubated for 30 min at 30 C with 0.01 ml of 3 2P-labelled MAP kinase in the absence (lanes 1
and 3) or presence (lanes 2 and 4) of 1 mM vanadate. The dephosphorylation of Thr 183 and Tyr 185 was then examined by phospho-
amino acid analysis as in (a). In (a) and (b), no dephosphorylation of p42mapk occurred in the presence of both vanadate and micro-
cystin, and the level of pT and pY in the presence of both inhibitors was the same as in control incubations, in which PC1 2 cell extract
was omitted (data not shown).
PP1, PP2A, PP2B and PP2C. PP1 and PP2A are active
in the absence of divalent cations and are the only phos-
phatases with significant activity towards phosphorylase,
whereas PP2B and PP2C have absolute requirements for
Ca2 + and Mg2+, respectively [23]. PP1 is inhibited specif-
ically by 200 nM inhibitor-2 and PP2A is inhibited by
2 nM okadaic acid [24].
The dephosphorylation of phosphorylase was inhibited
33 % by 2 nM okadaic acid and 69 % by inhibitor-2 in
dilute PC12 cell extracts (Table 1), showing that PP1
contributes about 70% and PP2A the remaining 30 % of
the phosphorylase phosphatase activity. In contrast, 2 nM
okadaic acid inhibited the dephosphorylation of p42mapk
and MAPKK by 79 % and 87 %, respectively, in the
absence of divalent cations, while inhibitor-2 had little
effect (Table 1). Thus, a PP2A-like enzyme was the
major phosphatase acting on p42mapk and MAPKK in
PC12 cell extracts.
As observed in other mammalian cells [25], three major
peaks of phosphorylase phosphatase activity were
detected when PC12 cell lysates were chromatographed
on Mono Q (Fig. 8a). The first phosphatase activity to
elute was unaffected by 2 nM okadaic acid, inactivated
by 200 nM inhibitor-2, and corresponds to PP1. The
second and third peaks were inactivated by 2 nM
okadaic acid, unaffected by inhibitor-2 (Fig. 8a), and
correspond to PP2A 1 and PP2A2 , respectively [25].
These species contain the same PP2A catalytic subunit
complexed to different regulatory subunits [23]. When
the fractions were assayed for phosphatase activity
towards p42mapk or MAPKK, two vanadate-insensitive
peaks were observed with each substrate, and the two
peaks co-eluted with PP2A1 and PP2A 2 (Figs 8b and 8c).
These phosphatases were inactivated by 2 nM okadaic
acid and unaffected by 200 nM inhibitor-2 (Figs 8b and
8c). The PP2A1 and PP2A2 peaks were pooled separ-
ately and incubated with a sheep antibody raised against
rabbit PP2A1. When coupled to protein G, this anti-
PP2A 1 antibody immunodepleted 95 % of the PP2A1
and 92 % of the PP2A2 phosphorylase phosphatase
activity, and 95 % and 91 % of p42mapk or MAPKK
phosphatase activities, respectively. Similar results were
obtained in three separate experiments and no immun-
odepletion occurred using pre-immune IgG. These
experiments indicate that PP2A (and not a distinct
PP2A-like enzyme) is the only significant phosphatase for
p42mapk and MAPKK in the Mono Q fractions.
MAPKK is dephosphorylated about five-fold more
rapidly than p42mapk by either PP2A1 or PP2A2 in vitro
(Fig. 8), consistent with the different rates of inactivation
of these two enzymes in vivo (Figs 1-3).
PP2B is inhibited by okadaic acid only at concentrations
above 500 nM, whereas PP2C is resistant to this toxin
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Fig. 7. Growth factors induce a micro-
cystin-insensitive, vanadate-sensitive
p42mapk phosphatase activity in PC12
and PAE cells. Cells were grown on 6 cm
dishes (7 x 106 cells) and preincubated
for 3 h in the absence (squares or closed
circles) or presence (open circles) of 40
ug ml ' cycloheximide (CHX). (a) 'Wild-
type' (WT) PC12 cells or mutant (Mut)
PC12 cells expressing HER(A1039-1053)
were stimulated with the growth factor
indicated in KRH buffer for the times
indicated (in the continued absence or
presence of cycloheximide). Cells were
lysed in the presence of 2 .M micro-
cystin to inactivate PP2A, and p42mapk
phosphatase activity measured relative
to that obtained in the absence of cy-
cloheximide or growth factors (5.5 
0.5 p.U mg- 1 protein). Similar results
were obtained in three separate experi-
ments. (b) PAE cells were stimulated
with the growth factors indicated as
in (a) and p42mapk phosphatase activity
was measured relative to that obtained
in the absence of CHX or growth fac-
tors (4.5 + 0.5 pgU mg-1 protein). The
p42mapk phosphatase activity in (a) and
(b) was completely inhibited by 1 mM
vanadate and similar results were
obtained in two separate experiments.
[24]. In the presence of 100 nM okadaic acid (to inhibit
PP2A), phosphatase activity towards p42mapk or MAPKK
was negligible in the presence, or absence, of Ca2 + , indi-
cating that PP2B does not make a significant contri-
bution to the dephosphorylation of either substrate
(Table 1). However, an okadaic acid-insensitive Mg 2+ -
dependent phosphatase activity was detected towards
MAPKK, but not p42mapk, indicating that PP2C dephos-
phorylates MAPKK in vitro. The okadaic acid-insensitive
activity in the presence of 10 mM and 1 mM Mg 2+ was
18 % and 10 %, respectively, of the okadaic aci-d-sensitive
activity in the absence of Mg2 + (Table 1).
The finding that PP2A is the major enzyme that inacti-
vates MAPKK in vivo is supported by other evidence. For
example, incubation of rat adipocytes with okadaic acid
triggers the activation of MAPKK in vivo [26], and
MAPKK is activated when the small-T antigen of simian
virus 40 is transiently expressed in CV-1 cells [27]. Small-
T antigen binds to the A subunit of PP2A and this seems
to compromise the ability of the phosphatase to inacti-
vate MAPKK, probably by exchanging with the 55 kD
B(x subunit. Transfection of CV-1 cells with genes
encoding mutant forms of small-T antigen that are
unable to interact with the A subunit does not trigger
activation of MAPKK [27].
Evidence that the dephosphorylation of Thr 183 and Tyr 185
of p42mapk in PC12 cells is catalysed by distinct enzymes
PC12 cells labelled with [32 P]orthophosphate were pre-
incubated for 3 hours with cycloheximide and then
stimulated with EGE The inactive p42mapk present in un-
stimulated PC12 cells was devoid of detectable phospho-
threonine or phosphotyrosine, whereas upon stimulation
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Fig. 8. Separation of protein phosphatases
in PC12 cell extracts by chromatography
on Mono Q. PC12 cells grown in four
flasks (75 cm2; 7 x 107 cells) were lysed
in 8 ml buffer A, centrifuged for 5 min at
14 000 x g and the supernatant applied
to a Mono Q column (5 x 0.5 cm) equili-
brated in buffer B containing 5 % (by vol-
ume) glycerol. After washing with buffer B
until the absorbance at 280 nm was zero,
the column was developed with a 40 ml
linear salt gradient to 0.5 M NaCI. The
flow rate was 1.0 ml min -1 and fractions
of 0.5 ml were collected. (a) The fractions
were assayed for phosphorylase phos-
phatase in the absence of phosphatase
inhibitors (open circles), in the presence
of 2 nM okadaic acid (open triangles) or
in the presence of 200 nM inhibitor-2
(closed circles). (b) The fractions were
assayed for p42mapk phosphatase activity
as in (a). No other peaks of vanadate-
insensitive activity were detected, other
than in the fractions shown. (c) The frac-
tions were assayed for MAPKK phos-
phatase activity as in (a). (d) The cells
were lysed in buffer A containing 2 M
microcystin and the column assayed in
the presence of 2 p.M microcystin using
p42mapk phosphorylated at both Thr 183
and Tyr 185 (open symbols) or mono-
phosphorylated p42mapk labelled specifi-
cally at Tyr 185 (closed symbols) as sub-
strates. The circles show activities in the
absence and the triangles activities in the
presence of mM sodium orthovanadate.
The broken lines show the NaCI gradi-
ents. The recovery of the vanadate-insen-
sitive p42mapk phosphatase activity
(PP2A 1 + PP2A2) from Mono Q was 70 %
and the recovery of the vanadate-sensitive
p42mapk phosphatase activity was > 90 %.
with EGF for 5 minutes (which activates p4 2mapk maxi-
mally, Fig. 2c), similar amounts of both phospho-amino
acids were generated (Fig. 9a). The p42mapk was inacti-
vated between 5 and 90 minutes after EGF stimulation,
Thr 183 and Tyr 185 being dephosphorylated at similar
rates (Fig. 9a). However, when 0.5 mM sodium ortho-
vanadate was included in the culture medium 5 minutes
prior to EGF addition, the rate of inactivation of MAP
kinase was unaffected (Fig. 9c), but the rate of Tyr 185
dephosphorylation relative to Thr 183 dephosphoryla-
tion was decreased three- to four-fold (Fig. 9b). Higher
orthovanadate concentrations were toxic to the cells.
Vanadate did not activate MAPKK or MAP kinase in
PC12 cells in the absence of EGF (Figs 9c and 9d), nor
did it affect the activation or inactivation of MAPKK
induced by EGF in vivo (Fig. 9d). Vanadate (1 mM) also
had no effect on MAPKK activity in vitro. These obser-
vations indicate that Thr 183 is dephosphorylated in
PC12 cells by a vanadate-insensitive enzyme (presumably
PP2A) and Tyr 185 is dephosphorylated by one or more
protein tyrosine phosphatases distinct from CL100.
Experiments in which okadaic acid was added to the
culture medium in order to specifically inhibit the
dephosphorylation of Thr 183 by PP2A could not be
interpreted, because this toxin prevents the inactivation
of MAPKK and hence promotes the phosphorylation of
both Thr 183 and Tyr 185 of p42mapk.
Detection of protein tyrosine phosphatase(s) acting on
p42mapk in unstimulated PC12 cells
The preceding results indicated that Tyr 185 and Thr 183
were dephosphorylated in vivo at similar rates after EGF
stimulation, Tyr 185 dephosphorylation being catalysed by
one or more vanadate-sensitive protein tyrosine phospha-
tases (Fig. 9b). However, in dilute extracts from unstim-
ulated PC12 cells, 93% ofthep42mapk phosphatase activity
was inhibited by microcystin and only 6% by vanadate
(Table 1). Consistent with these results, the major vana-
date-sensitive Tyr 185 phosphatase activity observed after
chromatography on Mono Q was detected (Fig. 8d) only
when the fractions were assayed at 30-fold lower dilutions
than those used to detect the later-eluting PP1 and PP2A
(Fig. 8b). Similar observations were made in Swiss 3T3
and PAE cells, in which 90 % and 79 % of the p42 mapk
phosphatase activity in lysates was inhibited by 2 M
microcystin, respectively, and the remainder by vanadate.
The low Tyr 185 phosphatase activity relative to the
Thr 183 phosphatase activity in cell extracts could be
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Fig. 9. Evidence that the dephosphoryla-
tion of Thr 183 and Tyr 185 of p42mapk
are catalysed by distinct protein phos-
phatases in EGF-stimulated PC12 cells.
(a) PC12 cells (2 x 107) were washed
with KRH buffer, then incubated for 3 h
at 37 C in 3.0 ml KRH buffer contain-
ing 1 mCi ml-1 [3 2P]-orthophosphate
and 40 pLg ml-1 cycloheximide. The
cells were stimulated with 100 ng ml-'
EGF for the times indicated, lysed, and
p42mapk immunoprecipitated, as
described in Materials and methods.
The immunoprecipitates were dena-
tured in 1 % SDS, heated for 5 min at
100° C, subjected to SDS-PAGE on
10% gels and 32P-labelled p42mapk
eluted from the gel and subjected to
phospho-amino acid analysis as in [10].
Abbreviations: pS, phosphoserine; pT,
phosphothreonine; pY, phosphotyro-
sine; Pi, orthophosphate. (b) As (a),
except that 0.5 mM sodium orthovana-
date was added to the medium 5 min
before stimulation with EGF. Cell lysates
from (a) (open circles) and (b) (closed
circles) were assayed in (c) for MAP
kinase activity (p42mapk plus p44mapk)
and in (d) for MAPKK activity. The open
triangles in (c) and (d) show MAP kinase
and MAPKK activities, respectively,
measured after incubating PC12 cells
with 0.5 mM vanadate in the absence of
EGF for the times shown.
explained by the loss of a PP2A inhibitor or of a Tyr 185
phosphatase activator, or if the Tyr 185 phosphatase was
unstable or required an unknown cofactor. However, the
failure of vanadate to affect the rate of inactivation of
MAP kinase in vivo, despite the marked inhibition of
Tyr 185 dephosphorylation (Fig. 9), suggested a further
possibility - namely that Thr 183 dephosphorylation
might be rate-limiting, Tyr 185 dephosphorylation being
inhibited by the phosphorylation of Thr 183. To exam-
ine this possibility, the Mono Q fractions were reassayed
with monophosphorylated p42mapk labelled specifically at
Tyr 185. The major peak of vanadate-sensitive p42mapk
phosphatase activity dephosphorylated p42mapk labelled
on Tyr 185 3.3-fold more rapidly than p42mapk labelled
on both Thr 183 and Tyr 185 (Fig. 8d).
Lack of regulation of p42mapk phosphatases by NGF and EGF
in PC12 cells
It has been reported that PP2A is inhibited in vitro by the
phosphorylation of a carboxy-terminal tyrosine residue,
catalysed by receptor protein tyrosine kinases or p60S rc,
and that PP2A is phosphorylated at this tyrosine residue(s)
in vivo [28]. To investigate whether PP2A was regulated
by phosphorylation, we lysed PC12 cells after stimulation
with NGF or EGF, in the presence of 1 mM sodium
orthovanadate to minimize tyrosine dephosphorylation of
PP2A; the lysis was in the largest possible volume of (ice-
cold) buffer that still permitted accurate measurement of
PP2A activity towards p42mapk and MAPKK. However,
even when assays were carried out immediately and for
the shortest possible time, we were unable to detect any
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effect of NGF or EGF treatment on PP2A activity
towards either substrate (Table 2). We were also unable
to detect any phosphorylation of the PP2A catalytic sub-
unit in quiescent or NGF-stimulated PC12 cells after lysis
of 3 2 P-labelled cells in the presence of microcystin and
vanadate, followed by quantitative immunoprecipitation
of PP2A1 and PP2A2 (data not shown).
It has also been reported that a vanadate-sensitive inacti-
vator of p44mapk present in PC12 cell extracts is inhibited
5 minutes after stimulation with NGF [29]. However,
we were unable to find any effect of NGF or EGF treat-
ment on vanadate-sensitive phosphatase activity towards
p42mapk up to 30 minutes after treatment (Fig. 7a).
Discussion
In mammalian cells, the activation of MAP kinase by
MAPKK takes place in the cytosol and is usually maxi-
mal about 5 minutes after stimulation with growth
factors. If the activation of MAP kinase is sustained,
the kinase is translocated to the nucleus, but this is a
relatively slow process taking 15-30 minutes in PC12
and Swiss 3T3 cells [4,6,30,31]. In contrast, no translo-
cation of MAPKK to the nucleus has been observed after
growth factor stimulation [30,31]. When growth factor
stimulation ceases, or growth factor receptors are down-
regulated, inactive MAP kinase reappears in the cytosol,
but whether dephosphorylation takes place before or
after MAP kinase is translocated back to the cytosol
is unknown.
In the present work, four different patterns of activation
and inactivation of MAPKK and MAP kinase were
observed after stimulation of cells with growth factors.
One pattern was seen in PAE cells stimulated with
PDGF, and in 3T3-L1 or PC12 cells stimulated with
EGF, in which the activation of MAPKK and MAP
kinase was transient, both enzymes peaking after 5 min-
utes and returning to near basal levels after 15-30 min-
utes (Figs 2 and 9d). In these situations, the rate of
inactivation of MAP kinase should be too rapid for sig-
nificant nuclear translocation to occur, and this is indeed
observed in EGF-stimulated PC12 cells [4]. MAP kinase
must therefore be inactivated in the cytosol, and our
results strongly suggest that inactivation is catalysed by
PP2A and a specific protein tyrosine phosphatase (Fig.
8; Table 1). The dephosphorylation of Thr 183 by
PP2A appears to be the rate-limiting step for inactiva-
tion in PC12 cells (Fig. 9). An involvement of CL100 or
CL100-like enzymes under these conditions can be
excluded, as no CL100-like activity can be detected up
to 30 minutes after growth factor stimulation (Fig. 7),
and blocking CL100 induction does not affect the rate
of inactivation of MAP kinase (Fig. 2). In addition,
recent work has revealed that CL100, like its homo-
logue PAC1 in haematopoetic cells [32], is localized to
the nucleus and not the cytosol (A. Sneddon and S. K.;
C. Marshall; J. Pouyssegur; personal communications).
The second pattern was seen in PAE cells after stimu-
lation with serum (Figs 3a and 3b) and in Swiss 3T3 cells
after stimulation with PDGF (Figs 3c and 3d) , in each of
which MAP kinase activation was sustained at a high
level for over 2 hours, even though the activation of
MAPKK was very transient (Fig. 3). In this situation,
p42mapk must clearly be protected from inactivation by
cellular phosphatases, but the mechanism of protection is
unclear. Translocation to the nucleus would protect
MAP kinase from cytosolic phosphatases, but further
devices are clearly needed to protect it from nuclear
PP2A [33] and from CL100, which is strongly induced
after 1 hour (Figs 4 and 7). These mechanisms might
include the interaction of MAP kinase with another pro-
tein (possibly a nuclear substrate), its location in a nuclear
compartment that prevents access of MAP kinase phos-
phatases, or the presence of nuclear inhibitors of PP2A
and/or CL100. The latter mechanism is an attractive pos-
sibility because it can explain why p42mapk inactivation
can be triggered by the overexpression of CL100. How-
ever, whatever the explanation, the important obser-
vation from the standpoint of this discussion is that the
activation of MAP kinase is sustained for at least 2 hours
in serum-stimulated PAE cells or PDGF-stimulated Swiss
3T3 cells, despite maximal induction of CL100 mRNA
and CL100-like activity (Fig. 4) and CL100 protein
(Fig. 7) after 1 hour.
The third pattern was seen in PC12 cells after stimula-
tion by NGF, in which the activation of both MAPKK
and MAP kinase was sustained for hours (Fig. 2d) [6];
this was also observed after stimulation with EGF in
PC12 cells transfected with an EGF receptor unable to
down-regulate (Fig. 7a). Under these conditions, MAP
kinase is maximally activated and largely translocated to
the nucleus after 60 minutes [6], while MAPKK remains
in the cytosol (C. Marshall, personal communication),
as observed in other cells [30,31]. Under such condi-
tions, the rate of inactivation of MAP kinase in PC12
cells was very slow up to 6 hours, despite an approxi-
mately 30-fold increase in CL100 mRNA and a propor-
tionally large increase in CL100-like activity after 1
hour (Fig. 7a). Moreover, if NGF was withdrawn after 4
hours, a time at which CL100 is maximally induced
(Fig. 7a), the rate of inactivation of MAP kinase was no
faster (50 % inactivation after 30 min) than if NGF was
withdrawn after 10 minutes (a time at which CL100 is
not induced; Figs 6 and 7).
The fourth pattern was seen in Swiss 3T3 cells after
stimulation with EGF, in which the activation of
MAPKK and MAP kinase were both transient, but the
inactivation of MAP kinase after 30 minutes (but not
the inactivation before 30 minutes) was prevented by
pretreatment of the cells with cycloheximide (Fig. 1).
This result is similar to an observation reported pre-
viously [16]: in serum-stimulated NIH 3T3 cells cyclo-
heximide prevents the inactivation of MAP kinase
occurring between 1 and 4 hours. MAP kinase is
translocated from the cytosol to the nucleus of Swiss
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3T3 cells after 15-30 minutes [31]. It is therefore possi-
ble that up to 30 minutes after stimulation, dephospho-
rylation is catalysed in the cytosol by a cycloheximide-
insensitive phosphatase (PP2A), and after 30 minutes in
the nucleus by a cycloheximide-sensitive phosphatase
(CL100). However, alternative explanations could ex-
plain the data. For example, cycloheximide might block
the synthesis of a protein that facilitates the dephospho-
rylation of MAP kinase by another nuclear phos-
phatase(s) or of a protein required to translocate MAP
kinase back to the cytosol (where it would be inactivated
by a cytosolic phosphatase).
The finding that CL100 is not involved in the inactiva-
tion of p42mapk in endothelial, adipose and chromaffin
cells under the conditions we have examined, or even in
fibroblasts stimulated with PDGF (Fig. 3), raises the
question of the physiological function of CL100.
Although CL100 displays a high degree of specificity for
p42mapk and p44,apk in vitro, it is also effective in
dephosphorylating other MAP kinase homologues, such
as FUS3 of S. cerevisiae (data of A. Gartner and S.K.,
cited in [34]), a kinase that participates in the yeast mat-
ing pathway. We have also found that CL100 is a potent
inactivator of another mammalian MAP kinase homo-
logue which is strongly activated by cellular stresses that
only weakly activate p42mapk and p44nmapk if at all [35].
Recall therefore, that CL100 was first identified as an
mRNA induced when fibroblasts were subjected to
chemical stress or heat shock [18]. This raises the possi-
bility that an important role of CLO100 is to inactivate
MAP kinase homologues that lie in distinct (stress-acti-
vated) signal transduction pathways. In fact, the induc-
tion of CL100 by growth factors could be a mechanism
for suppressing the activation of stress-induced MAP
kinase-like pathways, and perhaps their apoptotic effects.
Conclusions
The results in this paper demonstrate that, in several
mammalian cells, CL100 is not the enzyme that inacti-
vates p42mapk. In some situations, the activation of
p42"'apk is sustained at a high level for several hours,
despite the induction of maximal levels of CL100, indi-
cating that CL100 is unable to inactivate p42mapk in vivo
under these conditions. In other situations, in which
p42mapk is inactivated within 30 minutes, dephosphoryla-
tion is likely to be catalysed in the cell cytosol by PP2A
and a protein tyrosine phosphatase distinct from CL100.
Materials and methods
Materials
Murine p42 mapk was expressed as a glutathione S-transferase
(GST) fusion protein in Escherichia coli and purified [36]. Rabbit
MAPKKI, referred to in the text as MAPKK, and p74ra f- 1
were expressed as GST fusion proteins and purified as in [10].
Polyclonal antibodies were raised in sheep against rabbit PP2A1
purified as in [37]. The polyclonal antiserum-122, which
specifically recognises p42mapk, was a generous gift from C.J.
Marshall (Institute for Cancer Research, London). Myelin
basic protein, NGF, foetal calf serum and PDGF-BB were
purchased from Gibco/BRL (Paisley, UK). EGF and protein
A-Sepharose were purchased from Sigma (Poole, Dorset, UK).
Inhibitor-2, okadaic acid and microcystin were generous
gifts from A. DePaoli-Roach (Indiana University, USA),
Y. Tsukitani (Fujisawa Pharmaceutical, Tokyo) and G. Codd
(University of Dundee), respectively.
Buffer solutions
The following buffer solutions were used throughout this
study. Buffer A: 50 mM Tris-HC1, pH 7.5 (20 °C), 0.27 M
sucrose, 2 mM EDTA, 2 mM EGTA, 1 % (by vol) Triton X-
100, 0.1 % (by vol) 2-mercaptoethanol, 1 mM benzamidine,
and 0.2 mM phenylmethylsulphonylfluoride. Buffer B: 50 mM
Tris-HC1, pH 7.5 (200 C), 0.03 % (by mass) Brij-35, 0.1 mM
EGTA, and 0.1 % (by vol) 2-mercaptoethanol. Buffer C:
20 mM Tris-acetate, pH 7.0 (20 °C), 0.27 M sucrose, 1 mM
EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 10 mM
sodium glycerophosphate, 50 mM sodium fluoride, 5 mM
sodium pyrophosphate, 1 % (by mass) Triton X-100, 0.1 % (by
vol) 2-mercaptoethanol, I mM benzamidine and 0.2 mM
phenylmethylsulphonylfluoride. Krebs-Ringer-HEPES (KRH)
buffer: 25 mM HEPES, pH 7.4, 0.125 M NaCI, 4.8 mM KCI,
2.6 mM CaCl 2, 1.2 mM MgSO 4 and 5.6 mM glucose.
Cell culture and stimulation with growth factors
PAE endothelial cells transfected with the wild-type PDGF
receptor (a gift from L. Claesson-Welsh, Ludwig Institute for
Cancer Research, Uppsala, Sweden) and Swiss 3T3 fibroblasts
(a gift from H. Rozengurt, ICRF, London) were cultured to
confluence in Dulbecco's Modified Eagles Medium (DMEM)
containing 10% foetal calf serum, on plates 10 cm and 15 cm in
diameter, respectively. 3T3-LI cells were grown to confluence
on 10 cm dishes and differentiated to adipocytes by incubation
for two days with DMEM containing 10% foetal calf serum,
10 mM Hepes pH 7.4, 5 Lg ml- i insulin, 0.5 mM isobutyl-
methylxanthine, 0.25 mM dexamethazone ( > 80 % of cells
differentiated). PAE cells were deprived of serum for 16 h by
incubation in DMEM containing 1% foetal calf serum prior to
stimulation with 20 ng ml-l PDGF-BB or 10 % foetal calf
serum. Swiss 3T3 cells were incubated in DMEM containing
0.5 % foetal calf serum for 48 h prior to stimulation with
100 ng ml-1 EGF. 3T3-L1 cells were incubated for 3 h in
KRH buffer before stimulation with 100 ng m-1 EGF. After
stimulation with growth factors for the times indicated, each
dish of Swiss 3T3, PAE and 3T3-L1 cells was lysed in 0.4 ml of
ice-cold buffer C, and the lysates frozen immediately in liquid
nitrogen and stored at -80 °C. PC12 cells were cultured on
6 cm dishes (7 x 106 cells), stimulated with either 50 ng ml-1
NGF or 100 ng ml ' EGF [38] and lysed in 0.2 ml of Buffer C.
Lysates were thawed, centrifuged for 2 min at 13,000 x g and
the supernatants used as described below. PC12 cells expressing
a mutant human EGF receptor (HERA1039-1053) were
provided by A. Ullrich (Max Planck Institut, Martinsried,
Germany). Protein concentration was measured according to
Bradford [39].
Assay of MAP kinase and MAP kinase kinase
The immunoprecipitation and assay of p42mapk was carried out
as follows: lysate from PAE and 3T3-L1 cells (0.01 ml) or Swiss
3T3 cells (0.02 ml) was incubated for 90 min at 4 °C with 5 1l of
protein A-Sepharose conjugated to 1.0 Ipl anti-p42mapk 122 an-
tiserum. The suspension was centrifuged for 1 min at 14 000 xg,
the supernatant discarded, and the immunoprecipitate washed
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twice with 1.0 ml Buffer C containing 0.5 M NaC, once with
1.0 ml Buffer B, and assayed as described [38].
The total MAP kinase activity (p42mapk plus p4 4 mapk) was
measured in extracts from growth factor-stimulated PC12 cells
by the phosphorylation of myelin basic protein and corrected
for the activity measured in extracts from unstimulated cells
(which is catalysed by protein kinases distinct from MAP
kinase). This assay was validated in [38], where it was also
shown that p42mapk and p44mapk each account for about 50 %
of the total MAP kinase activity. We have also shown that these
enzymes are activated and inactivated in parallel after stimula-
tion with EGF (S. Traverse, unpublished experiments in our
laboratory). One unit of MAP kinase was that amount of
enzyme which catalysed the incorporation of 1 nmol phosphate
into myelin basic protein in 1 min.
MAPKK activity in 1 g cell lysate was assayed by the activa-
tion of bacterially expressed p42mapk [6]. One unit of MAPKK
was the amount that increased the activity of p42mapk by
1 unit per min.
Preparation of 32 P-labelled substrates and protein
phosphatase assays
Substrates were phosphorylated using [y- 32P]ATP with a spe-
cific activity of 1-2 cpm fmol- 1. Phosphorylase labelled with
32p (containing 1.0 mol phosphate per mol subunit) was pre-
pared using phosphorylase kinase [37]; 32P-labelled MAPKK1
(containing 0.9 mol phosphate per mol subunit) was phospho-
rylated equally at Ser 217 and Ser 221 with p74ra f- and freed
from [y- 32P]ATP by affinity chromatography on glutathione-
Sepharose [10]. The p42mapk labelled with 32p (containing
1.3 mol phosphate per mol subunit) was phosphorylated
equally at Thr 183 and Tyr 185 with activated MAPKK1.
The incubation was carried out for 120 min at 30 C in
Buffer B containing 4 mM MAP kinase, 0.4 p.M MAPKK1,
10 mM magnesium acetate, 0.2 mM [y- 32P]ATP, 1 M
okadaic acid, and 1 mM sodium orthovanadate. The reaction
was terminated by the addition of EDTA to 20 mM and the
32P-labelled p42mapk was purified on glutathione-Sepharose
[10]. The eluate was made 0.5 M in NaCl and passed through
a nickel nitrilotriacetate agarose column (0.5 ml) equilibrated
in buffer B containing 0.5 M NaCl to remove the His-tagged
MAPKK1. The flow-through fractions containing 32P-labelled
p42mapk were concentrated to 0.2 ml by ultrafiltration through
a Centricon 30 membrane, rediluted to 2 ml in Buffer B,
reconcentrated to 0.2 ml and this process repeated once more.
The p4 2mapk substrate was then diluted in buffer B to give
a final concentration of 32p of 3 pIM. Unless stated otherwise,
all p42mapk phosphatase assays were carried out with
diphosphorylated p42mapk labelled at Thr 183 and Tyr 185.
In order to prepare monophosphorylated p42mapk phosphory-
lated at Tyr 185, for the experiment in Fig. 8d, 32P-labelled
p4 2m apk (2 nmol 32 P-radioactivity) was bound to 0.2 ml of glu-
tathione-Sepharose equilibrated in buffer B containing
1 mg ml-1 bovine serum albumin and incubated for 2 h at
30 C with PP2A (100 mU ml- 1). The glutathione-Sepharose
beads were washed twice with 1.0 ml Buffer B containing
0.5 M NaCl, three times with Buffer A and the p42mapk eluted
and prepared for phosphatase assays as described above. PP2A
removed 50 % of the 32P-radioactivity from the diphosphory-
lated p42mapk, and phospho-amino acid analysis confirmed that
Thr 183 was completely dephosphorylated. A further aliquot
of diphosphorylated p42mapk was treated identically, except
that PP2A was replaced by buffer, and used as a control.
To measure p42mapk phosphatase activities, PC12 cells were
lysed in 02 ml ice-cold Buffer A, centrifuged for 5 min
at 14 000 x g, and the lysates assayed for protein phospha-
tase activities by the release of trichloroacetic acid-soluble
32P-radioactivity from the proteins [37], or after extraction of
the phosphate-molybdate complex into isobutanol/heptane
[26]. The latter procedure establishes that the released 32p_
radioactivity is present as orthophosphate and not as small
phosphopeptides produced by the action of proteinases. To
assay vanadate-sensitive phosphatases, 2 M microcystin was
included in the lysis buffer, and to measure microcystin-sensi-
tive phosphatases, lmM sodium orthovanadate was included in
the lysis buffer. The 32P-labelled substrate concentrations in the
phosphatase assays were 10 pM phosphorylase, 1 M p42 mapk,
and 1 .M MAPKK1. Caffeine (5 mM) was added when phos-
phorylase was the substrate [37]. The dephosphorylation of
each substrate was limited to less than 10 %, to ensure that the
release of phosphate was linear with time; 1 mU protein phos-
phatase activity was the amount of enzyme that catalysed the
release of 1 nmol of phosphate from each substrate in 1 min. In
order to inhibit PP1, diluted phosphatases were incubated with
inhibitor-2 for 15 min at 30 C before initiating the assays.
DNA probe preparation and northern analysis
Random-primed DNA synthesis using restriction fragments
isolated from low melting-point agarose gels was used to pre-
pare 32P-labelled probes. Total RNA for northern blotting
was isolated from PC12, Swiss 3T3 and PAE cells, using the
one-step acid guanidinium thiocyanate/phenol/chloroform
extraction. Human CL100 cDNA [18] was then used to probe
for the CL100 sequence by northern blot analyses. The
nucleotide sequence of the rat CL100 homologue has been
submitted to the GenBank/EMBL database (accession number
RRU 02553). As the human and rat cDNA sequences are
87 % identical, northern blots were probed and washed at high
stringency, then re-probed with a 32 P-labelled fragment of the
rat glyceraldehyde-3-phosphate dehydrogenase cDNA as a
control. Quantitation of CL100 hybridization signals was done
using a Bio-Rad GS-250 molecular phosphorimager.
Acknowledgements: We thank C. Marshall for providing bacteria
expressing MAPKK and p42mapk, and for p4 2 mapk antibodies; U.
Rapp for baculoviruses required to express Raf, and Y. Saito for
help in cell culture. D.A. acknowledges a Postdoctoral Training
Fellowship from the U.K. Medical Research Council. This study
was supported by Medical Research Council and The Royal
Society (P.C.) and by the Imperial Cancer Research Fund (S.K.).
References
1. Sturgill TW, Wu J: Recent progress in characterization of protein
kinase cascades for phosphorylation of ribosomal protein S6.
Biochim Biophys Acta 1991, 1092:350-357.
2. Pages G, Lenormand P, L'Allemain G, Chambard J-C, Meloche S,
Pouyssegur J: Mitogen-activated protein kinases p42(mapk) and
p44(mapk) are required for fibroblast proliferation. Proc Natl Acad
Sci USA 1993, 90:8319-8323.
3. Cowley S, Paterson H, Kemp P, Marshall C: Activation of MAP
kinase kinase is necessary and sufficient for PC12 differentiation
and for transformation of NIH 3T3 cells. Cell 1994, 77:841-852.
4. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A:
EGF triggers neuronal differentiation of PCI2 cells that overexpress
the EGF receptor. Curr Biol 1994, 4:694-701.
5. Chen RH, Sarnecki C, Blenis : Nuclear localization and regulation
of erk- and rsk-encoded protein kinases. Mol Cell Biol 1992,
12:915-927.
6. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P: Sustained
activation of the mitogen-activated protein (MAP) kinase cascade
MAP kinase phosphatases Alessi et al.
may be required for differentiation of PC12 cells. Comparison of
the effects of nerve growth factor and epidermal growth factor.
Biochem J 1992, 288:351-355.
7. Anderson NG, Mailer J, Tonks NK, Sturgill TW: Requirement for
integration of signals from two distinct phosphorylation pathways
for activation of MAP kinase. Nature 1990, 343:651 653.
8. Payne DM, Rossomando AJ, Martino P, Erikson AK, Her JH,
Shabanowitz J, et al.: Identification of the regulatory phosphoryla-
tion sites in pp42/mitogen-activated protein kinase (MAP kinase).
EMBOJ 1991, 10:885-892.
9. Zhang F, Strand A, Robbins D, Cobb MH, Goldsmith : Atomic
structure of the MAP kinase ERK2 at 2.3 Angstrom resolution.
Nature 1994, 367:704-710.
10. Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U
et al.: Identification of the sites in MAP kinase kinase-1 phosphory-
lated by p74raf '. EMBO J 1994, 13:1610-1619.
11. Zheng CF, Guan KL: Activation of MEK family kinases requires
phosphorylation of two conserved Ser/Thr residues. EMBO J 1994,
13:1123-1131.
12. Gomez N, Cohen P: Dissection of the protein kinase cascade by
which nerve growth factor activates MAP kinases. Nature 1991,
353:170-1 73.
13. Nakielny S, Cohen P, Wu J, Sturgill TW: MAP kinase activator from
insulin-stimulated skeletal muscle is a protein threonine/tyrosine
kinase. EMBOJ 1992, 11:2123-2129.
14. Sarcevic B, Erikson E, Maller JL: Purification and characterization of
a mitogen-activated protein kinase tyrosine phosphatase from
Xenopus eggs. I Biol Chem 1993, 268:25075-25083.
15. Alessi DR, Smythe C, Keyse SM: The human CL100 gene encodes a
Tyr/Thr-protein phosphatase which potently and specifically inacti-
vates MAP kinase and suppresses its activation by oncogenic ras in
Xenopus oocyte extracts. Oncogene 1993, 8:2015-2020.
16. Sun H, Charles CH, Lau LF, Tonks NK: MKP-1 (3CH134), an imme-
diate early gene product, is a dual specificity phosphatase that
dephosphorylates MAP kinase in vivo. i7ell 1993, 75:487-493.
17. Zheng CF, Guan KL: Dephosphorylation and inactivation of the
mitogen-activated protein kinase by a mitogen-induced Thr/Tyr
protein phosphatase. I Biol Chem 1993, 268:16116-16119.
18. Keyse SM, Emslie EA: Oxidative stress and heat shock induce a
human gene encoding a protein-tyrosine phosphatase. Nature
1992, 359:644-646.
19. Charles CH, Sun H, Lau LF, Tonks NK: The growth factor-inducible
immediate-early gene 3CH134 encodes a protein-tyrosine phos-
phatase. Proc Natl Acad Sci USA 1993, 90:5292-5296.
20. Kahan C, Seuwen K, Meloche S, Pouyssegur J: Coordinate, biphasic
activation of p44 mitogen-activated protein kinase and S6 kinase by
growth factors in hamster fibroblasts. Evidence for thrombin-
induced signals different from phosphoinositide turnover and
adenylyl cyclase inhibition. J Biol Chem 1992, 267:13369'-13375.
21. Wu J, Lau LF, Sturgill TW: Rapid deactivation of MAP kinase in
PC12 cells occurs independently of induction of phosphatase
MKP-1. FEBS Lett 1994, 353:9-12.
22. MacKintosh C, Beattie KA, Klumpp S, Cohen P, Codd GA:
Cyanobacterial microcystin-LR is a potent and specific inhibitor of
protein phosphatases 1 and 2A from both mammals and higher
plants. FEBS Lett 1990, 264:187-192.
23. Cohen P: The structure and regulation of protein phosphatases.
Annu Rev Biochem 1989, 58:453-508.
24. Cohen P, Holmes, CF, Tsukitani Y: Okadaic acid: a new probe for
the study of cellular regulation. Trends Biochem Sci 1990, 15:
98-102
25. Ferrigno P, Langan TA, Cohen P: Protein phosphatase 2A, is the
major enzyme in vertebrate cell extracts that dephosphorylates
several physiological substrates for cyclin-dependent protein
kinases. Mol Biol Cell 1993, 4:669 677.
26. Haystead TAJ, Weiel JE, Litchfield DW, Tsukitani Y, Fischer EH,
Krebs EG: Okadaic acid mimics the action of insulin in stimulating
protein kinase activity in isolated adipocytes. I Biol Chem 1990,
265:16571-16580.
27. Sontag E, Federov S, Kamibayashi C, Robbins D, Cobb M, Mumby
M: The interaction of SV40 small tumour antigen with protein
phosphatase 2A stimulates the map kinase pathway and induces
cell proliferation. Cell 1994, 75:887-897.
28. Chen J, Parsons S, Brautigan DL: Tyrosine phosphorylation of pro-
tein phosphatase 2A in response to growth stimulation and v-src
transformation of fibroblasts. I Biol Chem 1994, 269:7957-7962.
29. Peraldi P, Scimeca JC, Filloux C, Van Obberghen E: Regulation of
extracellular signal regulated protein kinase-1 (ERK-1, pp44-mito-
gen activated protein kinase) by epidermal growth factor and nerve
growth factor in PC12 cells-implications of ERKI inhibitory acti-
vities. Endocrinology 1993, 132:2578-2585.
30. Lenormand P, Sardet C, Pages GC, L'Allemain GC, Brunet A,
Pouyssegur J: Growth factors induce nuclear translocation of MAP
kinases (p42(mapk) and p44(mapk)) but not their activator MAP
kinase kinase (p45(mapkk)) in fibroblasts. J Cell Biol 1993, 122:
1079-1088.
31. Zheng CF, Guan KL: Cytoplasmic localization of the mitogen-acti-
vated protein kinase activator MEK. J Biol Chem 1994, 269:
19947-19952.
32. Ward Y, Gupta S, Jensen P, Wortmann M, Davis RJ, Kelly K: Control
of MAP kinase activation by the mitogen-induced threonine/tyro-
sine phosphatase PAC1. Nature 1994, 367:651-654.
33. Jakes S, Mellgren RL, Schlender KK: Isolation and characterisation
of an inhibitor-sensitive and a polycation-stimulated protein phos-
phatase from rat liver nuclei. Biochim Biophys Acta 1986, 888:
135-142.
34. Gartner A: The role of protein phosphatases in the adaption to the
pheromone response in yeast. Adv Protein Phosphatases 1994,
8:153-1 62.
35. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A,
Zamanillo D, et al.: A novel kinase cascade triggered by stress and
heat shock that stimulates MAPKAP kinase-2 and phosphorylation
of the small heat shock proteins. Cell 1994, 78:1027-1037.
36. Stokoe D, Campbell DG, Nakielny S, Hidaka H, Leevers S, Marshall
CJ, Cohen P: MAPKAP kinase-2; a novel protein kinase activated by
mitogen-activated protein kinase. EMBO J 1992, 11:3985-3994.
37. Cohen P, Alemany S, Hemmings BA, Resink TJ, Stralfors P, Tung HL:
Protein phosphatase-1 and protein phosphatase-2A from rabbit
skeletal muscle. Methods Enzymol 1988, 159:390-408.
38. Gomez N, Tonks NK, Morrison C, Harmer T, Cohen P: Evidence for
communication between nerve growth factor and protein tyrosine
phosphorylation. FEBS Lett 1990, 271:119-122.
39. Bradford MM: A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-
dye binding. Anal Biochem 1976, 72:248-254.
Received: 20 October 1994; revised: 12 December 1994.
Accepted: 6 January 1995.
RESEARCH PAPER 295
